INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Search warrant served at Indiana doctor's office
Authorities served a search warrant at a Muncie clinic as part of an ongoing investigation into the possible overprescribing of prescription…
94-year-old vet recovering after robbery, attack
Investigators have made arrests in the violent assault and robbery of a 94-year-old central Indiana veteran.
Can the Ebola virus be contained?
An Indiana University doctor who witnessed the Ebola epidemic unfold in West Africa is giving insight on the risk of an outbreak in the U.S.
Jockeys to honor late teenage rider Juan Saez
Jockeys nationwide will honor the 17-year-old apprentice who was killed in a riding accident recently.
Police: Not enough evidence to connect 3 deaths
There were looming questions about the causes of death of three women who were found in the same vacant lot over the past four months.
Ind. murder suspect killed in Alabama shooting
A man wanted in connection to an Indianapolis homicide was killed over the weekend in Alabama, officials said.